OP0171 PHASE 3 TRIAL OF LENABASUM, A CB2 AGONIST, FOR THE TREATMENT OF DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS (DCSSC)
暂无分享,去创建一个
D. Furst | J. Gordon | C. Denton | D. Khanna | L. Hummers | M. Matucci-Cerinic | O. Distler | R. Spiera | B. White | M. Kuwana | T. Frech | S. Kafaja | W. Stevens | S. Constantine | N. Dgetluck | Eunsik Lee | Yair Levy | Jae-Bum Jun | Y. Levy